Protara Therapeutics Inc (TARA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2024 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Protara Therapeutics Inc  (NASDAQ: TARA)


Protara Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Protara Therapeutics Inc's ROI in the second quarter of 2026?
Protara Therapeutics Inc recorded a cumulative net loss of $-67 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -41.71%.

Within the Healthcare sector 336 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 0 to 3550.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 57.05 % 110.55 % 75.77 % 66.26 % 20.06 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 163 200 135 147 170
Return On Investment (TTM) -41.71 % -35.75 % -38.83 % -38.84 % -43.47 %
TARA's Overall Ranking # 3550 # 0 # 3430 # 3199 # 2953
Seq. Investment Change TTM -1.18 % 21.26 % 7.76 % 21.63 % 32.48 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -67 -58 -52 -48 -45

TARA Company Profile >> Back to TARA Roi Comparisons >> See Annual TARA Return On Investment



Return On Investment TARA's Ranking
Within: No.
Industry # 45
Sector # 337
Overall # 3550

Return On Investment Statistics
High Average Low
-10.27 %
-56.21 %
-155.38 %
(Sep 30 2015)   (Dec 31 2019)



  News about Protara Therapeutics Inc Return on Investment ROI

Protara Therapeutics Sees Stock Surge Following Positive Trial Results, Faces Financial Hurdles as It Aims for 2025 Milestones,

January 13, 2025

Protara Therapeutics Reports Promising Trial Results Amidst Financial ChallengesProtara Therapeutics Inc. a biopharmaceutical company focused on advancing therapies for rare diseases, has recently highlighted significant updates and anticipated milestones for 2025. Notably, the company reported positive six-month data from the ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC). This announcement has bolstered investor confidence, pushing Protara’s stock price up an impressive 106.4% above its 52-week average on the NASDAQ.Despite this promising clinical progress, Protara also revealed a challenging financial landscape. During the 12 months ending in the third quarter of 2024, the company recorded a cumulative net loss of $42 million, resulting in a negative return on investment (ROI) of -47.42%. In the competitive healthcare sector, this financial performance places Protara at a disadvantage, with 451 other companies demonstrating a higher ROI during the same period.





Financial Statements
Protara Therapeutics Inc's II. Quarter Investments $ 163 Millions TARA's Balance sheet
Protara Therapeutics Inc's II. Quarter Income $ -22 Millions Quarterly TARA's Income Statement
TARA's Income by Division See TARA's Income by Division


TARA Annual Return On Investment (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022
Total Investments in Millions 183 162 170 70 108
Y / Y Investment Growth 13.28 % -5.25 % 143.94 % -35.01 % -36.1 %
Net Income in Millions -18 -12 -45 -40 -66
Y / Y Net Income Growth - - - - -
Annual Return On Investment -9.72 % -7.38 % -26.16 % -57.83 % -61.32 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TARA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TARA's Competitors
Subscribers only: Roi for Protara Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for TARA's Customers

Other Ratios
TARA's Roa TARA's Inventory Turnover Ratio TARA's Growth Rates TARA's Dividend Statistics
TARA's Profitability Ratios TARA's Asset Turnover Ratio TARA's Dividend Growth
TARA's Roe TARA's Valuation Ratios TARA's Financial Strength Ratios TARA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:10:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.